Press release
Carba Announces 5-Year Carbon Removal Credit Purchase Agreement with Microsoft
Image: https://storage.googleapis.com/mmstudio-images/gallery/m9LZLuSQtlP19VRpxBwa4DFeLRm1/1745517264481-0.jpgCarba, a Minneapolis, Minnesota carbon removal company, announced an agreement today to deliver 44,000 carbon removal credits to Microsoft over a 5 year period. Carba's novel pyrolysis technology and burial method removes carbon dioxide, storing biochar underground in low-oxygen environments based on a patented, highly efficient pyrolysis reactor.
Carba's autothermal technology offers greater energy efficiency, stabilizing carbon from biogenic waste and turning it into economically valuable biochar with high carbon content. The biochar will be used as an alternate daily cover and buried in a local landfill, protecting it from degradation and possibly providing environmental co-benefits. The biochar's properties have the potential to act like an activated carbon filter in the landfill, which could reduce odors, remediate pollutants (e.g., PANs, PCBs, dioxins and furans), and increase gas pollutant absorption. The environmental co-benefits will be further evaluated during project operations.
"We're thrilled to contribute to Microsoft's portfolio by providing high-quality carbon removal credits that will be retired starting this year," said Andrew Jones, CEO, Carba. "Our fully integrated approach-combining biomass sourcing, processing, and secure storage-enables us to scale quickly while having the potential to deliver significant community co-benefits."
Image: https://www.globalnewslines.com/uploads/2025/04/e48d00a4e4f8259aae9424cac2c6f297.jpg
"By co-locating biomass supply chain delivery, pyrolysis, and end-use & storage, Carba's biochar burial offers the potential to become a scalable and cost-effective climate solution," said Brian Marrs, Senior Director for Energy & Carbon Removal at Microsoft. "This agreement with Carba allows us to better explore the future of this biochar end-use and the possible co-benefits, while benefiting from the near-term delivery of these credits with a straightforward-monitoring and verification process.
Last year, this project was selected to receive a $7 million grant from the Department of Energy for a Carbon Negative Shot Pilot (FOA 382).
The project's methodology has been certified by Isometric with 1,000-year durability credits. [https://isometric.com/writing-articles/new-certified-module-for-biochar-storage#:~:text=Biochar%20can%20be%20stored%20in,which%20maintains%20low%20oxygen%20conditions.]
"Isometric's rigorous scientific validation ensures that each credit represents a permanently removed ton of carbon dioxide," said Stacy Kauk, Chief Science Officer at Isometric.
About Carba:
Carba converts waste biomass and organic materials into stable biocarbon for use in materials, pollution management, and permanent carbon dioxide removal. Carba has developed a patented autothermal process and a patented anoxic burial method to impart 1,000+ year certified carbon removal. The company was founded by Dr. Andrew Jones and Professor Paul Daueunhauer, experts with a combined 40+ years of experience in pyrolysis and valorizing biomass. Carba is backed by GigaClimate Builder, founded by Nick Halla (founding team, past executive at Impossible Foods).
Carba's first deployment is with a waste disposal company converting municipal wood waste into biocarbon for use as daily cover in the landfill, sequestering carbon and adsorbing pollutants within the landfill. Carba is a versatile, efficient, and scalable permanent carbon removal solution.
For more, visit www.carba.com [http://www.carba.com/]
Media Contact
Company Name: Carba
Contact Person: Patricia Loria
Email: Send Email [http://www.universalpressrelease.com/?pr=carba-announces-5year-carbon-removal-credit-purchase-agreement-with-microsoft]
Phone: 1-202-531-6513
Address:3315 Miller Heights Road
City: Oakton
State: Virginia
Country: United States
Website: http://www.carba.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Carba Announces 5-Year Carbon Removal Credit Purchase Agreement with Microsoft here
News-ID: 3986943 • Views: …
More Releases from Getnews
The U.S. Green Card: Turning a Temporary Stay into a Permanent American Future
Image: https://www.globalnewslines.com/uploads/2025/12/1766183100.jpg
For many people, a U.S. visa is only the beginning. What they truly want is certainty - the ability to live, work, and plan their future in the United States without expiry dates, renewals, or ongoing fear that a single decision could unravel years of effort.
That certainty is called a Green Card.
Yet despite its importance, the Green Card [https://larhdellaw.com/] process is often misunderstood. Some believe it is only for…
The L-1 Visa: How Global Businesses Expand to the U.S. Without Starting From Scr …
Image: https://www.globalnewslines.com/uploads/2025/12/1766182907.jpg
For international companies with ambitions to enter the United States, few visa options are as powerful - or as misunderstood - as the L-1 Intracompany Transfer Visa.
When used correctly, the L-1 visa allows established businesses to expand into the U.S. market, transfer trusted senior staff, and build a long-term American presence without relying on lotteries, third-party sponsors, or speculative investment routes. When used incorrectly, it becomes one of the…
The B-1/B-2 Visitor Visa: Why Careful Preparation Matters More Than Ever
Image: https://www.globalnewslines.com/uploads/2025/12/1766182346.jpg
The B-1/B-2 visitor visa [https://larhdellaw.com/]is often described as the most common U.S. visa. That description, while true, can be misleading. Its familiarity causes many applicants to underestimate how closely these visas are scrutinised - and how easily an application can be refused.
In today's immigration environment, visitor visas are assessed with a level of caution that surprises even experienced international travellers. The rules themselves have not dramatically changed, but how…
The E-2 Visa Explained: How to Invest in the U.S. Without Buying a Green Card (a …
Image: https://www.globalnewslines.com/uploads/2025/12/1766182716.jpg
For entrepreneurs, investors, and business owners looking to live and work in the United States, the E-2 Treaty Investor Visa remains one of the most attractive - and misunderstood - visa options available.
Every year, we speak with applicants who have invested significant money, launched businesses, or even hired staff, only to discover that their E-2 application was refused or delayed due to avoidable legal and strategic errors. The truth…
More Releases for Carba
Virology And Bacteriology Market Anticipated To Witness Robust Growth, Surpassin …
The Virology And Bacteriology Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Virology And Bacteriology Market Size and Its Estimated Growth Rate?
The virology and bacteriology market will grow from $2.44 billion in 2024 to $2.67 billion in 2025 at a compound…
Virology And Bacteriology Global Market Growth Opportunities, Emerging Trends, I …
"The Business Research Company recently released a comprehensive report on the Global Virology And Bacteriology Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Clinical Microbiology Market Drivers and Restraints 2017-2025 : Hologic Inc., Be …
Global Clinical Microbiology Market: Overview
The intercontinental clinical microbiology market is envisioned to be pampered by a wide spectrum of opportunities in different applications such as the identification of diseases caused by pathogens with the help of laboratory services. Class A carbapenemase, a group of causative agents of clinical infections, is proliferating rapidly and has augmented the need for determining carbapenemase genes through clinical microbiology. In order to address this need,…
Clinical Microbiology Market - Global Industry Analysis, Growth Rate By 2025
Global Clinical Microbiology Market: Overview
The intercontinental clinical microbiology market is envisioned to be pampered by a wide spectrum of opportunities in different applications such as the identification of diseases caused by pathogens with the help of laboratory services. Class A carbapenemase, a group of causative agents of clinical infections, is proliferating rapidly and has augmented the need for determining carbapenemase genes through clinical microbiology. In order to address this need,…
Clinical Microbiology Market - Estimation, Forecast, demands and development ana …
Global Clinical Microbiology Market: Overview
The intercontinental clinical microbiology market is envisioned to be pampered by a wide spectrum of opportunities in different applications such as the identification of diseases caused by pathogens with the help of laboratory services. Class A carbapenemase, a group of causative agents of clinical infections, is proliferating rapidly and has augmented the need for determining carbapenemase genes through clinical microbiology. In order to address this need,…
Clinical Microbiology Market - Global Industry Size, Share, Analysis, Trend & Fo …
Global Clinical Microbiology Market: Overview
The intercontinental clinical microbiology market is envisioned to be pampered by a wide spectrum of opportunities in different applications such as the identification of diseases caused by pathogens with the help of laboratory services. Class A carbapenemase, a group of causative agents of clinical infections, is proliferating rapidly and has augmented the need for determining carbapenemase genes through clinical microbiology. In order to address this need,…
